These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 7014583)

  • 1. Comparison of enzyme-labelled F(ab')2 and IgG conjugates in an enzyme-immunoassay for hepatitis B 'e' antigen.
    van der Waart M; Snelting A; Bruijnis F; Prins-Bekius M; Bos E; Katchaki J; Schuurs A
    J Virol Methods; 1980 Dec; 2(1-2):85-96. PubMed ID: 7014583
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development of an enzyme-linked immunosorbent assay (ELISA) for hepatitis B e antigen and antibody.
    Smith AM; Tedder RS
    J Virol Methods; 1981 Jul; 3(1):1-11. PubMed ID: 7021574
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An enzyme immunoassay for hepatitis B e-antigen and antibody.
    Mushahwar IK; Overby LR
    J Virol Methods; 1981 Sep; 3(2):89-97. PubMed ID: 7024294
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Detection of hepatitis Be antigen with an enzyme immunoassay (author's transl)].
    Lange W; Masihi KN
    Zentralbl Bakteriol A; 1980 Aug; 247(3):296-302. PubMed ID: 6999797
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Enzyme-immunoassay in diagnosis of hepatitis with emphasis on the detection of "e" antigen (HBeAg).
    von der Waart M; Snelting A; Cichy J; Wolters G; Schuurs A
    J Med Virol; 1978; 3(1):43-9. PubMed ID: 104001
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A study of the evolution of specific and non-specific immune complexes in acute hepatitis B and chronic hepatitis.
    Leyva A; Bernal MC; Piedrola G; Maroto MC
    J Med Microbiol; 1988 Jul; 26(3):237-9. PubMed ID: 3392730
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Spontaneous development of anti-hepatitis B virus envelope (anti-idiotypic) antibodies in animals immunized with human liver endonexin II or with the F(ab')2 fragment of anti-human liver endonexin II immunoglobulin G: evidence for a receptor-ligand-like relationship between small hepatitis B surface antigen and endonexin II.
    Hertogs K; Depla E; Crabbé T; De Bruin W; Leenders W; Moshage H; Yap SH
    J Virol; 1994 Mar; 68(3):1516-21. PubMed ID: 8107214
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Detection of HBeAg among HBsAg-positive patients with various hepatic diseases and epidemiologic significance of the findings].
    Xu HW
    Zhonghua Liu Xing Bing Xue Za Zhi; 1983 Aug; 4(4):226-9. PubMed ID: 6640636
    [No Abstract]   [Full Text] [Related]  

  • 9. [Immunoenzyme analysis for determining class G and M antibodies to HBsAg].
    Sokolenko AA; Slavin MN; Shakhanina KL
    Zh Mikrobiol Epidemiol Immunobiol; 1988 Feb; (2):99-103. PubMed ID: 3129891
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hepatitis B e antigen in volunteer and paid blood donors.
    Tabor E; Goldfield M; Black HC; Gerety RJ
    Transfusion; 1980; 20(2):192-8. PubMed ID: 6966088
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Radioimmunoassay for hepatitis B 'e' antigen and antibody: correlations with viral replication and prognostic value.
    Baraldini M; Facchini A; Miglio F; Ramadori G; Alberti A; Realdi G
    Vox Sang; 1981 Sep; 41(3):139-45. PubMed ID: 7331287
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [HBeAg and anti-HBe in asymptomatic carriers of HBsAg and in various forms of hepatitis and liver cirrhosis].
    Kalinowska B; Nazarewicz-de Mezer T; Krawczyński K
    Przegl Epidemiol; 1984; 38(3):249-56. PubMed ID: 6528039
    [No Abstract]   [Full Text] [Related]  

  • 13. Significance of tests for HBeAg and anti-HBe in HBsAg positive blood donors.
    Dow BC; Macvarish I; Barr A; Crawford RJ; Mitchell R
    J Clin Pathol; 1980 Nov; 33(11):1106-9. PubMed ID: 7440758
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Clinical significance of HBeAg and anti-HBe in HBsAg positive liver diseases].
    Takahashi A; Sekiya C; Yazaki Y; Tominaga Y; Oohara K; Ono M; Sato H; Hasebe C; Namiki M
    Hokkaido Igaku Zasshi; 1983 Jan; 58(1):30-42. PubMed ID: 6840666
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hepatic infections. Part I. A serological evaluation of Fab antigens (Fab' and F (ab)2) and antibodies in patients and asymptomatic carriers of hepatitis B virus.
    Vos GH; Marimuthu T; Vos D
    S Afr Med J; 1979 Nov; 56(19):751-56. PubMed ID: 505209
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antiidiotypic activity in the IgM fractions of mixed cryoglobulins.
    Geltner D; Franklin EC; Frangione B
    J Immunol; 1980 Oct; 125(4):1530-5. PubMed ID: 6774023
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HBeAG and anti-HBe in the Malaysian population and in Malaysian prisoners.
    Ton SH; Lopez CG; Noriah R
    Southeast Asian J Trop Med Public Health; 1983 Jun; 14(2):252-4. PubMed ID: 6635764
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [HBeAg and anti-HBe levels in HBsAg positive blood donors].
    Hasçelik G; Günalp A
    Mikrobiyol Bul; 1989 Jan; 23(1):23-9. PubMed ID: 2626096
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Detection of both hepatitis B e antigen and antibody in a single assay using monoclonal reagents.
    Ferns RB; Tedder RS
    J Virol Methods; 1985 Jul; 11(3):231-9. PubMed ID: 4030995
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hepatitis B virus DNA in hepatitis B surface antigen-positive blood donors: relation to the hepatitis B e system and outcome in recipients.
    Krogsgaard K; Wantzin P; Aldershvile J; Kryger P; Andersson P; Nielsen JO
    J Infect Dis; 1986 Feb; 153(2):298-303. PubMed ID: 3944482
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.